Peter Gibbs-Publications

Peter Gibbs-Publications

Selected publications

  1. Cohen J, Li L, Wang Y, Thorburn C, Afsari B, Danilova L, Douville C, Jave A, Wong F, Mattox A, Hruban R, Wolfgang C, Goggins M, Dal Molin M, Wang T, Roden R, Klein A, PTak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein J, Browne J, Schoen R, Brand R, Tie J, Gibbs P, Wong H, Mansfield A, Jen J, Hanash S, Falconi M, Allen P, Zhou S, Bettegowda C, Diaz L, Tomasetti C, Kinzler K, Vogelstien B, Lennon A, Papadopoulos N. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018 Feb 23;359(6378):926-930. PMID: 29348365
  2. Gibbs P, Wasan H, Sharma N, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee P, Dutton P, Love S, Gebski A, Sharma R, van Hazel G. The FOXFIRE prospective randomised studies of first-line selective internal radiotherapy in patients with liver metastases from colorectal cancer. Lancet Oncol. 2017 Sep;18(9):1159-1171. PMID: 28781171
  3. Cohen J, Javed A, Thoburn C, Tie J, Gibbs P, Schmidt M, Yip-Schneider M, Allen P,  Brand R, Falconi M, Hong S, Petersen G, Weiss B, Ahuja N, He J, Makary M, Maitra A,  Hanash S, Wong F, Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaeffer J, Silliman N, Popoli M, Goggins M, Hruban R, Wolfgang C, Klein A, Tomasetti C, Papadopoulos N,  Kinzler K, Vogelstein B, Lennon A. A combined circulating tumor DNA and protein biomarker assay for the earlier detection of pancreatic cancer. Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10202-10207. PMID: 28874546
  4. Rohr U, Herrmann P, Ilm K, Zhang H, Lohmann S, Reiser A, Muranyi A, Smith J, Burock S, Osterland M, Leith K, Singh S, Brunhoeber P, Bowermaster R, Tie J, Christie M,  Wong H, Waring P, Shanmugam K, Stein U, Gibbs P. Combination of DNA Mismatch Repair Status and MACC1 Expression in Patients with Stage II Colon Cancer:  The BIOGRID Studies. Ann Oncol. 2017 Aug 1;28(8):1869-1875 PMID: 28460000
  5. Tie, J, Wang Y, Springer S, Kinde I, Wong HL, Christie M, Tacey M, Kosmider S,  Skinner I, Wong R, Steel M, Tran B, Desai J, Jones I, Haydon A, Price T, Hayes T, Strausberg R, Diaz L, Papadopoulos N, Kinzler K, Vogelstein B, Gibbs P. Serial circulating tumor DNA sampling to inform the management of stage II colon cancer. Sci Transl Med. 2016 Jul 6;8(346):346ra92. doi: 10.1126/scitranslmed.aaf6219. PMID: 27384348
  6. Ghosh P, Tie J, Muranyi A, Singh S, Brunhoeber P, Leith K, Bowermaster R, Liao Z, Zhu Y, LaFleur B, Tran B, Desai J, Jones I, Croxford M, Martinez R, Goel A, Waring P, Hu S, Teichgraeber V, Rohr U, Ridder R, Shanmugam K, Gibbs P. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair Proficient Stage II Colon Cancer. Clin Cancer Res. 2016 Jul 15;22(14):3488-98. PMID: 27029492
  7. Tie J, Kinde I, Wang Y, Wong H, Roebert J, Christie M, Tacey M, Wong R, Singh M, Karapetis C, Desai J, Tran B, Strausberg R, Diaz L, Papadopoulos N, Kinzler K, Vogelstein B, Gibbs P. Circulating Tumor DNA as an Early Marker of Therapeutic Response in Patients with Metastatic Colorectal Cancer. Ann Oncol. 2015 Aug;26(8):1715-22. PMID: 25851626
  8. Bettegowda C, Sausen M, Leary R, Kinde I, Wang Y, Agrawal N, Bartlett B, Wang H, Luber B, Alani R, Antonarakis E, Azad N, Bardelli A, Brem H, Cameron J, Choti M, Clarence L, Fecher L, Gallia G, Gibbs P, Le D, Giuntoli R, Goggins M, Hogarty M, Holdhoff M, Hong S, Jiao Y, Juhl H, Kim J, Siravegna G, Laheru D, Lauricella C, Lim M, Lipson E, Nagahashi S, Netto G,  Oliner K, Olivi A, Olsson A, Riggins G, Sartore-Bianchi A, Schmidt K, Shih L, Shinjo S, Siena S, Theodorescu D, Tie J, Hawkins T, Veronese S, Wang S, Weingart J, Wolfgang C, Wood L, Xing D, Hruban R, Wu J, Velculescu V, Kinzler K, Vogelstein B, Papadopoulos N, Diaz L. Circulating tumor DNA for the detection and monitoring of human malignancies. Sci Transl Med. 2014 Feb 19;6(224):224ra24. doi: 10.1126/scitranslmed.3007094. PMID: 24553385
  9. Tie J, Lipton L, Desai J, Gibbs P, Jorissen R, Christie M, Drummond K, Thomson B, Usatoff V, Evans P, Pick A, Knight S, Carne P, Berry R, Polglase A, McMurick P, Zhao Q, Busam D, Strausberg R, Dimingo E, Tomlinson I, Midgley R, Kerr D, Sieber O. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clin Cancer Res. 2011 Mar 1;17(5):1122-30. PMID: 21239505
  10. Tie J, Gibbs P, Lipton L, Jorissen R, Burgess AW, Croxford M, Jones I, Langland R, Kosmider S, McKay D, Bollag G, Nolop K, Sieber OM, Desai J. Optimizing Targeted Therapeutic Development: Enriching the Colorectal Cancer Patient Population for the BRAFV600E Mutation. Int J Cancer. 2011 May 1;128(9):2075-84. PMID: 20635392

 

Further publications